Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

From shareholder letter "Regarding our cash, I met recently with the board of directors and we decided not to pay out a dividend this period. We’ll revisit this issue regularly but for now I think we can put that cash to much better use in growing the company, as I hope to show you later this year."

http://www.ptsc.com/news/press_releases/20070905.asp

Share
New Message
Please login to post a reply